Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $71.7 Billion
- Q1 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 68,790 shares of ALNY stock, worth $17.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,790
Previous 56,144
22.52%
Holding current value
$17.1 Million
Previous $10.7 Million
4.34%
% of portfolio
0.01%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding ALNY
# of Institutions
585Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.18 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.98 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.24 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.79 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.65 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...